NCT02268955 is a NA clinical trial of IV Ibuprofen in Biliary Colic, sponsored by Valleywise Health.

Who is sponsoring NCT02268955?

NCT02268955 is sponsored by Valleywise Health.

What drugs are being tested in NCT02268955?

Interventions in NCT02268955: IV Ibuprofen, Saline.

What condition does NCT02268955 study?

NCT02268955 studies Biliary Colic.

Is NCT02268955 still recruiting?

NCT02268955 is currently completed. Last updated 14 May 2019.

Are results published for NCT02268955?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-05-14 · How we verify

NCT02268955

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Analgesic Efficacy of Intravenous Ibuprofen in Biliary Colic

Completed NA Results posted Last updated 14 May 2019

What this trial tests

NA trial testing IV Ibuprofen in Biliary Colic in 22 participants. Completed in 28 June 2017.

Timeline

9 September 2014

Primary endpoint
21 June 2017

28 June 2017

Quick facts

Lead sponsor	Valleywise Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	22
Start date	9 September 2014
Primary completion	21 June 2017
Estimated completion	28 June 2017
Sites	1 location across United States

Drugs / interventions tested

IV Ibuprofen — full drug profile →
Saline

Conditions studied

Biliary Colic — all drugs for Biliary Colic →

Sponsor

Valleywise Health — full company profile →

Who can join

Adults 18 to 55, any sex, with Biliary Colic. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Pain Score 120 Minutes After Study Medication Administration Primary · 120 minutes post medication administration

Pain is measured on a visual analog scale 0=no pain and 10=worst pain imaginable.

Group	Value	95% CI
Control Group: Adults Age 18-55 Years	3.0	0.0 – 7.0
IV Ibuprofen: Adults Age 18-55 Years	0.3	0.0 – 8.0

Sponsor's own description

The aim of this study is to assess the analgesic efficacy of intravenous ibuprofen given in the Emergency Department for the treatment of biliary colic. We hypothesize that intravenous ibuprofen will provide a clinically significant drop in self-reported patient pain level as measured by the visual analog scale.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Non-steroid anti-inflammatory drugs for biliary colic.
Fraquelli M, Casazza G, Conte D, Colli A. · · 2016 · cited 11× · PMID 27610712 · DOI 10.1002/14651858.cd006390.pub2

Verify or expand the search:

Other trials of IV Ibuprofen

Trials testing the same drug.

NCT02689063 — Maxigesic IV Phase 3 Bunionectomy Study · Phase 3 · completed

Other recruiting trials for Biliary Colic

Currently open trials in the same condition.

NCT07222527 — One vs. Two Stents for Gallbladder Disease · NA · recruiting

Other Valleywise Health trials

Trials by the same sponsor.

NCT05081375 — Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures · Phase 4 · terminated
NCT02609568 — Salivary Biomarkers in Pediatric Traumatic Brain Injury · completed
NCT01981434 — Technology Based Obesity Prevention Project (TeBOPP) · NA · completed
NCT01258244 — Arizona Prehospital CPR Quality Improvement Project · completed
NCT01245699 — MIHS Emergency Department CPR Quality Improvement Project · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02268955 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Valleywise Health
Last refreshed: 14 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02268955.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing